http://hdl.handle.net/1765/13173

pubmed: 12821586



Drug-eluting stents: cost versus clinical benefit.


Article
volume 107, issue 24 pp 3003-3007.
Related Files

(publisher's version.url.txt, 52 bytes)
Repository contains one additional file which is not publicly available

The publication in January 2001 of the first-in-man results showing zero restenosis after sirolimus-eluting stent implantation produced enormous excitement in the cardiological community. The long-awaited tool—a safe, restenosis-proof, easy-to-use stent— had been found. It was not too long thereafter that paclitaxel-eluting stents also demonstrated their capability to decrease restenosis.



Keywords




Bookmark with: